{'fraction_non_alphanumeric': 0.015228426395939087, 'fraction_numerical': 0.017766497461928935, 'mean_word_length': 4.915, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Tolerance by Gene Therapy Induction of Central Deletional T Cell

Transgenic mice expressing an alloreactive TCR speciﬁc for the MHC class I Ag K b were used to examine the mechanism by which genetic engineering of bone marrow induces T cell tolerance. Reconstitution of lethally irradiated mice with bone marrow infected with retroviruses carrying the MHC class I gene H-2K b resulted in lifelong expression of K b on bone marrow-derived cells. While CD8 T cells expressing the transgenic TCR developed in control mice reconstituted with mock-transduced bone marrow, CD8 T cells expressing the transgenic TCR failed to develop in mice reconstituted with H-2K b transduced bone marrow. Analysis of transgene-expressing CD8 T cells in the thymus and periphery of reconstituted mice revealed that CD8 T cells expressing the transgenic TCR underwent negative selection in the thymus of mice reconstituted with K b transduced bone marrow. Negative selection induced by gene therapy resulted in tolerance to K b . Thus, genetic engineering of bone marrow can be used to alter T cell education in the thymus by inducing negative selection. The Journal of Immunology, 2002, 169: 1930–1935.